Rare diseases
Investigational molecules
Locations
733 Industrial Road, 94070-3310, United States
Glycomine Inc. focuses on PMM2-CDG, a rare inherited metabolic disorder affecting protein glycosylation and multiple organ systems.
The sponsor’s clinical activity centers on this ultra-rare disease area, with research spanning pediatric, adolescent, and adult populations.
Glycomine Inc. runs clinical trials in conditions such as Metabolic disorder, Congenital disorder of glycosylation, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Long-Term Safety Study of GLM101 for Patients with PMM2-CDG
CzechiaStudy on the Effects and Safety of GLM101 for Patients with PMM2-CDG
BelgiumStudy on the Effects of GLM101 for Patients with PMM2-CDG
SpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
